Macquarie Bank Ltd Warrant on Sino Biopharmaceutical Limited (23678)
Market Closed
HKEX HKEX Primary - Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
HKD
Previous Close Want to track 23678 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
23678 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
23678 Chart
Macquarie Bank Ltd Warrant on Sino Biopharmaceutical Limited (23678) FAQ
What is the stock price today?
The current price is 0.00 HKD.
On which exchange is it traded?
Macquarie Bank Ltd Warrant on Sino Biopharmaceutical Limited is listed on HKEX.
What is its stock symbol?
The ticker symbol is 23678.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Macquarie Bank Ltd Warrant on Sino Biopharmaceutical Limited ever had a stock split?
No, there has never been a stock split.
Macquarie Bank Ltd Warrant on Sino Biopharmaceutical Limited Profile
| Financial Services Industry | Financials Sector | - CEO | HKEX Exchange | - ISIN |
| Hong Kong Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Macquarie Bank Ltd Warrant on Sino Biopharmaceutical Limited is a European-style call derivative warrant issued by Macquarie Bank Ltd. It provides investors exposure to the performance of Sino Biopharmaceutical Limited, a leading Hong Kong-listed pharmaceutical company focused on modernized Chinese medicines, chemical medicines, and innovative drug development in oncology, liver diseases, respiratory conditions, and analgesia. This standard, non-collateralized, cash-settled warrant features a strike price of HKD 9.777, an entitlement ratio of 5 warrants per underlying share (conversion ratio 0.2), and trades in HKD with a board lot size of 5,000 warrants. Launched on December 16, 2025, and listed on December 19, 2025, it matures on November 23, 2026, with a total issue size of 66,670,000 warrants and an initial issue price of HKD 0.150. As a structured product, it enables leveraged participation in the underlying stock's price movements above the strike, subject to time decay and volatility influences, playing a role in derivatives markets for tactical trading and hedging strategies tied to the healthcare sector.
Contact Information
Address: -
Phone: -
